Advertisement
Perspective

Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

EGFR Inhibition in Non-Small Cell Lung Cancer: Resistance, Once Again, Rears Its Ugly Head

  • Published: February 22, 2005
  • DOI: 10.1371/journal.pmed.0020075

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

How Tumor Cells Acquire Resistance to Kinase Inhibitors

Synopsis | published 22 Feb 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020074

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

William Pao, Vincent A Miller, Katerina A Politi, Gregory J Riely, Romel Somwar, Maureen F Zakowski, Mark G Kris, Harold Varmus
Research Article | published 22 Feb 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020073